激素避孕方法与异位妊娠保护效应
基于瑞典2005至2016年处方登记数据,纳入1,663,242名15-49岁使用激素避孕的女性,按避孕方法计算异位妊娠发生率。结果显示激素避孕显著降低异位妊娠风险,但13.5mg左炔诺孕酮宫内节育系统的异位妊娠发生率明显高于其他激素避孕方法。
要点
- 13.5mg左炔诺孕酮宫内节育系统异位妊娠发生率为2.76/1000女性年(95%CI 2.26-3.35)。
- 52mg左炔诺孕酮宫内节育系统发生率为0.30/1000女性年(95%CI 0.28-0.33)。
- 复方口服避孕药发生率为0.20/1000女性年(95%CI 0.19-0.22),为所报告方法中最低。
核心结论
- 激素避孕显著降低异位妊娠风险。
- 使用低剂量激素宫内节育系统(13.5mg左炔诺孕酮)的女性异位妊娠发生率明显高于使用其他类型激素避孕的女性。
- 本研究提供真实世界证据,以指导以女性为中心的避孕咨询的最佳临床实践。
研究设计与样本
- 基于瑞典处方药物登记册的队列研究,纳入2005年至2016年间有激素避孕药处方的15-49岁女性。
- 共纳入1,663,242名女性,记录1,915例异位妊娠事件。
- 暴露女性年按避孕方法分配至治疗时段,治疗时间从处方配药日开始,至供应结束、新的合格配药、妊娠相关诊断及相应估计末次月经或取出操作之日结束。
- 异位妊娠定义为30天内至少两次国际疾病分类第十版编码O00-(包括O00.0、O00.1、O00.2、O00.8、O00.9)记录,或一次O00-记录加一次异位妊娠手术操作(NOMESCO手术分类编码LBA、LBC、LBD、LBE、LBW)。
- 计算每种避孕方法的每1000女性年发生率及95%CI。
主要发现
- 13.5mg左炔诺孕酮激素宫内节育系统异位妊娠发生率为2.76/1000女性年(95%CI 2.26-3.35)。
- 52mg左炔诺孕酮激素宫内节育系统发生率为0.30/1000女性年(95%CI 0.28-0.33)。
- 复方口服避孕药发生率为0.20/1000女性年(95%CI 0.19-0.22)。
- 孕激素植入剂发生率为0.31/1000女性年(95%CI 0.26-0.37)。
- 口服中等剂量孕激素(去氧孕烯75mg)发生率为0.24/1000女性年(95%CI 0.21-0.27);口服低剂量孕激素(炔诺酮0.35mg和利奈孕醇0.5mg)发生率为0.81/1000女性年(95%CI 0.70-0.93)。
临床怎么用
- 原文结论指出激素避孕显著降低异位妊娠风险,且低剂量激素宫内节育系统(13.5mg左炔诺孕酮)的异位妊娠发生率明显高于其他激素避孕方法。
- 原文结论指出本研究提供真实世界证据,以指导以女性为中心的避孕咨询的最佳临床实践。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the incidence rates for ectopic pregnancy by contraceptive method in a cohort of women using hormonal contraception in Sweden between 2005 and 2016. METHOD: Women aged 15-49 years with a filled prescription for a hormonal contraceptive in the Swedish Prescribed Drug Register between 2005 and 2016 were included. For each woman, all exposed woman-years were allocated to treatment episodes depending on the method of contraception. Treatment time started on the day the prescription was filled and ended on the first day of the end of supply, new eligible dispensing, pregnancy-related diagnosis and its associated estimated last menstrual period, or removal procedure. Ectopic pregnancy was defined as having at least two records of International Classification of Diseases, Tenth Revision code O00-, including O00.0, O00.1, O00.2, O00.8, O00.9, within 30 days or one episode of O00- and one surgical procedure for ectopic pregnancy (NOMESCO Classification of Surgical Procedures code LBA, LBC, LBD, LBE, LBW). Incidence rates per 1,000 woman-years and 95% CIs were calculated for each method of contraception. RESULTS: The study included 1,663,242 women and 1,915 events of ectopic pregnancy. The incidence rate (95% CI) for ectopic pregnancy per method of hormonal contraception was estimated: 13.5-mg levonorgestrel (LNG) hormonal intrauterine device (IUD), 2.76 (2.26-3.35) per 1,000 woman-years; 52-mg LNG hormonal IUD, 0.30 (0.28-0.33) per 1,000 woman-years; combined oral contraception, 0.20 (0.19-0.22) per 1,000 woman-years; progestogen implants, 0.31 (0.26-0.37) per 1,000 woman-years; oral medium-dose progestogen (desogestrel 75 mg), 0.24 per 1,000 woman-years, (0.21-0.27); and oral low-dose progestogen (norethisterone 0.35 mg and lynestrenol 0.5 mg), 0.81 (0.70-0.93) per 1,000 woman-years. CONCLUSION: Hormonal contraception lowers the risk of ectopic pregnancy markedly. The incidence rate of ectopic pregnancy among women using a low-dose hormonal IUD (13.5 mg LNG) was substantially higher than that in women using other types of hormonal contraception. This study provides real-world evidence to inform best clinical practice for women-centered contraceptive counseling.
引用
- Kopp-Kallner H, Linder M, Cesta CE, et al. Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy. Obstet Gynecol. 2022. PMID: 35576335. doi:10.1097/AOG.0000000000004726
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。